Activity of terminal deoxynucleotidyl transferase (TdT), adenosine deaminase, and 5'nucleotidase and the cellular concentration ofglucocorticoid (dexamethasone) receptor were determined in 25 patients with acute non-lymphocytic leukaemia. All patients were treated according to a common protocol. Increased activity of TdT ( > 0 1 unit/,ug DNA) was found in 11 patients. This group of patients was shown to have higher remission and survival rates (p = 006) compared with patients with low activity of TdT. The glucocorticoid receptor concentration of the leukaemic blast cells ranged from 0 to 0-94 fmol/4g DNA.
Introduction
Immunological and cytochemical classification of subgroups in acute leukaemia has in the past few years raised the hope of more accurate diagnosis and differentiated treatment. Moreover, biochemical studies have identified marker enzymes that will aid in the subclassification of acute leukaemia. At present two such enzyme markers, terminal deoxynucleotidyl transferase (TdT) and hexosaminidase, appear to be of definite value. In children the activity of TdT is high in the T and common type of acute lymphocytic leukaemia (non-T-non-B), while patients with B-cell-derived leukaemias have low activity of the enzyme. ' Isoenzyme analysis of hexosaminidase has shown that "common acute lymphocytic leukaemia" in children has a distinct and easily identifiable pattern.2 Accordingly, measurements of the cellular TdT activity and hexosaminidase isoenzyme pattern will subclassify acute lymphocytic leukaemia as being of the T, B, or common type. Since common acute lymphocytic leukaemia in children has a much better prognosis than acute lymphocytic leukaemia of T-or B-cell origin analysis of hexosaminidase and TdT activity obviously has great practical implications.
Activity of TdT is generally low in acute non-lymphocytic leukaemia,' although occasional cases of acute myeloblastic leukaemia with raised TdT activity have been reported.3 It has also been reported that the presence of detectable TdT activity in blast cells from patients with chronic myelocytic leukaemia in blastic crisis predicts a high response rate to chemotherapy.4 The state of two other enzymes, 5'nucleotidase and adenosine deaminase, is less certain. Activity of 5'nucleotidase appears to be lower in mature than immature lymphocytes; and it is considerably decreased in chronic lymphocytic leukaemia, suggesting its usefulness as a marker for cellular differentiation. So far little is known about the activity of 5'nucleotidase in acute non-lymphocytic leukaemia.5 Adenosine deaminase was initially suggested as a marker for blast cells in acute lymphocytic leukaemia, but some patients with acute non-lymphocytic leukaemia also show high activity of the enzyme. TdT activity-The table shows that 11 of the patients had TdT activities of 0 4-19 2 units/,ig DNA while 14 patients had low activities (undetectable to 0-09 units/,ug DNA). Figure 2 compares the survival of the 11 patients with high (.>0 1 units/[zg DNA) TdT activity with the survival of the 14 patients with low (< 0 1 units/,ug DNA) TdT activity. Survival appeared to be increased in the 11 patients with increased activity (p=0 06, log-rank test). The survival of the six young patients with TdT activity over 01 units/,ug DNA was com-pared separately with that of the nine young patients with low TdT activity. Figure 3 shows a significantly increased survival (p =0 035, log-rank test) in the young patients with high TdT activity. should be correlated with our finding that TdT activity is also associated with increased survival and remission rates in acute non-lymphocytic leukaemia. We should emphasise that the TdT activity in our patients was low, which indirectly rules out that some with acute lymphocytic leukaemia had been misdiagnosed as having acute non-lymphocytic leukaemia. This is also supported by cytochemical and morphological analysis. The possibility still exists, however, that increased TdT activity indicates the presence of two blast populations, one lymphoid TdT-positive and a second myeloid or monocytic TdT-negative, as has been described by Mertelsmann et al. 15 We thus conclude that measurements of glucocorticoid receptor concentrations and TdT activity contribute partially independent prognostic information. When both are decreased a group of patients with a much decreased survival is identified.
In view of our findings we think that measurement of glucocorticoid receptor concentration and TdT activity should be considered in the design of future prospective studies of acute non-lymphocytic leukaemia.
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users.' Tobacco smoke contains over 3000 chemicals and some of the constituents (polycyclic aromatic hydrocarbons) are enzyme-inducers. In pharmacokinetic studies the rate of metabolism of some drugs-for example, phenacetin and antipyrine-is increased in cigarette smokers. In contrast, no effect of smoking has been observed on the disposition of other drugs-for example, diazepam and phenytoin.' The metabolism of ethinyloestradiol may be important in relation to toxicity: a metabolite of ethinyloestradiol becomes irreversibly bound to protein of human hepatic microsomes,3 and this could be the starting point of an immunological mechanism leading to an adverse reaction. Consistent with this, anti-ethinyloestradiol antibodies have been detected in oral contraceptive users.4
The aim of our study was twofold: to find out whether oral contraceptives fall into the group of drugs whose overall rate of metabolism is affected by smoking, and to see whether this might account for the increased toxicity.
Subjects, methods, and results
We studied 311 women taking oral contraceptives containing 30 ,ug ethinyloestradiol (Eugynon 30, Microgynon, and Ovranette). A blood sample was obtained from each woman, and we recorded the time of the last pill, her weight, age, whether she smoked (and the number of cigarettes per day), and any other medication. Plasma
